CYP3A5 polymorphism in kidney transplantation: individualizing tacrolimus dosing

被引：0
|
作者：
Pasari, Amit S. [1 ,2 ]
Balwani, Manish R. [1 ,2 ]
Bawankule, Charulata [1 ,2 ]
Sejpal, Kapil [1 ]
Gurjar, Prasad [1 ]
Kashiv, Pranjal [1 ]
Dubey, Shubham [1 ]
Malde, Sunny [1 ]
Gupta, Sushrut [1 ]
Pawar, Twinkle [1 ]
机构：
[1] JNMC, Nephrol, Wardha, India
[2] Saraswati Kidney Care Ctr, Nephrol, Nagpur, Maharashtra, India
来源：
TRANSPLANTATION | 2024年 / 108卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
302.4
引用
收藏
页码：170 / 170
页数：1
相关论文
共 50 条
  • [21] Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation
    Asberg, Anders
    Midtvedt, Karsten
    van Guilder, Mike
    Storset, Elisabet
    Bremer, Sara
    Bergan, Stein
    Jelliffe, Roger
    Hartmann, Anders
    Neely, Michael N.
    TRANSPLANT INTERNATIONAL, 2013, 26 (12) : 1198 - 1207
  • [22] A CONCEPTUAL ECONOMIC MODEL FOR CYP3A5 PHARMACOGENETIC-GUIDED TACROLIMUS THERAPY IN KIDNEY TRANSPLANTATION
    Deininger, K.
    Campbell, J.
    Aquilante, C. L.
    VALUE IN HEALTH, 2020, 23 : S325 - S326
  • [23] Effects of Genetic Polymorphism in CYP3A4 and CYP3A5 Genes on Tacrolimus Dose Among Kidney Transplant Recipients
    Yousef, Al-Motassem
    Qosa, Hisham
    Bulatova, Nailya R.
    Abuhaliema, Ali
    Almadhoun, Hussein
    Khayyat, Ghada
    Olemat, Muhammad
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2016, 10 (03) : 156 - 163
  • [24] Risk of Tacrolimus Toxicity in CYP3A5 Nonexpressors Treated With Intravenous Nicardipine After Kidney Transplantation
    Hooper, David K.
    Fukuda, Tsuyoshi
    Gardiner, Rhonda
    Logan, Barbara
    Roy-Chaudhury, Ashwini
    Kirby, Cassie L.
    Vinks, Alexander A.
    Goebel, Jens
    TRANSPLANTATION, 2012, 93 (08) : 806 - 812
  • [25] Personalized Tacrolimus Doses Determined by CYP3A5 Genotype for Induction and Maintenance Phases of Kidney Transplantation
    Vannaprasaht, Suda
    Reungjui, Sirirat
    Supanya, Darika
    Sirivongs, Dhavee
    Pongskul, Cholatip
    Avihingsanon, Yingyos
    Tassaneeyakul, Wichittra
    CLINICAL THERAPEUTICS, 2013, 35 (11) : 1762 - 1769
  • [26] Polymorphism of the CYP3A5 Gene and Its Effect on Tacrolimus Blood Level
    Nair, Sreeja S.
    Sarasamma, Sreeja
    Gracious, Noble
    George, Jacob
    Anish, Thekkumkara Surendran Nair
    Radhakrishnan, Reghunathan
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2015, 13 : 197 - 200
  • [27] MARGINAL ADVANTAGE OF KNOWING PATIENT'S CYP3A5 GENOTYPE FOR TACROLIMUS DOSING
    Asberg, Anders
    Midtvedt, Karsten
    Guilder, Mikevan
    Storset, Elisabet
    Bremer, Sara
    Bergan, Stein
    Jelliffe, Roger
    Hartmann, Anders
    Neely, Michael
    TRANSPLANT INTERNATIONAL, 2013, 26 : 198 - 198
  • [28] Study on the regularity between CYP3A5/3A4 polymorphism in medication of tacrolimus after renal transplantation
    Guo, Yuan-yuan
    Jiang, Wen-tao
    Shen, Zhong-yang
    Zhang, Yi
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 37 - 37
  • [29] Study on the regularity between CYP3A5/3A4 polymorphism in medication of tacrolimus after renal transplantation
    Acta Pharmacologica Sinica, 2013, 34 (Suppl 1) : S37 - S42
  • [30] Impact of CYP3A5 Genetic Polymorphism on Intrapatient Variability of Tacrolimus Exposure in Chinese Kidney Transplant Recipients
    Cheung, Chi Yuen
    Chan, Koon Ming
    Wong, Yuen Ting
    Chak, Wai Leung
    Bekers, Otto
    van Hooff, Johannes P.
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (06) : 1754 - 1757
12345